The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions
Passali Desiderio, Cingi Cemal, Staffa Paola, Passali Francesco, Muluk Nuray Bayar, Bellussi Maria Luisa,
소속 상세정보
( Passali Desiderio )
University of Siena Department of Otorhinolaryngology-Head and Neck Surgery
( Cingi Cemal )
Osmangazi University Department of Otorhinolaryngology-Head and Neck Surgery
( Staffa Paola )
University of Siena Department of Otorhinolaryngology-Head and Neck Surgery
( Passali Francesco )
University of Roma Tor Vergata ENT Clinic
( Muluk Nuray Bayar )
Kirikkale University Faculty of Medicine Department of Otorhinolaryngology-Head and Neck Surgery
( Bellussi Maria Luisa )
University of Siena Department of Otorhinolaryngology-Head and Neck Surgery
Abstract
Background: Allergic rhinitis (AR) is a global health problem and is characterised by one or more symptoms, including sneezing, itching, nasal congestion and rhinorrhea.
Objective: We investigated the features of AR and the physician's approach to the management of AR patients in four geographical regions.
Methods: In this cross-sectional study, a questionnaire survey concerning AR was completed by Honorary and Corresponding Members of the Italian Society of Rhinology from different countries among 4 world geographical regions?Asia, Europe, the Americas, and Africa.
Results: The prevalence of AR was reported to be 15%?25%. Children and adolescents, as well as young adults, were the age groups more affected by AR with comorbidities of asthma, sinusitis, conjunctivitis, and nasal polyposis. Nasal symptoms of AR were more intense in the spring (51.92%) and autumn (28.85%). The most common aero-allergens were pollen and mites (67.31%), animal dander and pollutants (23.08%), and fungal allergens (21.15%). Allergen-specific immunotherapy was prescribed for both perennial and seasonal allergens (32.69%) via sublingual swallow (46.15%) and subcutaneous (32.69%) routes. For the AR patients, the most prescribed drugs were intranasal corticosteroids (86.54%) and oral H1-antihistamines (82.69%).
Conclusion: A network of experts can improve our knowledge concerning AR epidemiology, and together with guidelines, could assist practitioners and otolaryngologists in standardising the diagnosis and treatment of AR.
키워드
Allergic rhinitis; Allergens; Treatment; Allergen specific immunotherapy; Sublingual immunotherapy; Subcutaneous immunotherapy
원문 및 링크아웃 정보
등재저널 정보